News

Yahoo Finance3mon
WuXi Biologics Included in S&P Global Sustainability Yearbook 2025
Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, March 10, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development ...
Nasdaq1y
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale
SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...
FiercePharma1y
WuXi Biologics, WuXi AppTec plot manufacturing expansions in US, China
but that’s not keeping WuXi AppTec and WuXi Biologics from continuing their ambitious expansion efforts. In China, WuXi AppTec has commissioned two new peptide manufacturing plants. The ...
Newswire2y
WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody
SHANGHAI, Oct. 11, 2022 /CNW/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Toregem BioPharma, a biotech ...